epsilon n-dimethyllysine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
*Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Miao, F; Min, A; Natarajan, R; Smith, DD; Zhang, L | 1 |
1 other study(ies) available for epsilon n-dimethyllysine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.
Topics: Adolescent; Adult; Child; Child, Preschool; Chromatin; Cohort Studies; Diabetes Mellitus, Type 1; Environment; Epigenesis, Genetic; Genetic Predisposition to Disease; Histones; Humans; Insulin-Secreting Cells; Lymphocytes; Lysine; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; T-Lymphocytes; Young Adult | 2008 |